Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 4 Drug Alert (Caution in use): Aurum Pharmaceuticals Limited - Acetylcysteine 200 mg/ml Injection - EL(10)A/13 Rev 1

Document details:

Type: Drug Alert
Series No: EL (10)A/13 Rev 1
Audience: Healthcare professionals
Published:
Format: Electronic and paper
Size: A4
Pages: 2
Price: Free
ISBN/ISSN:
Author:
Copyright: Crown
   

Help viewing PDFs:

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

DRUG ALERT

CLASS 4 MEDICINES DEFECT INFORMATION
Caution in Use
Distribute to Hospital Pharmacists and A & E Departments
28 June 2010 EL (10)A/13 Rev 1 Our ref:  MDR 44-06/10

Dear Healthcare Professional,

Aurum Pharmaceuticals Limited

Acetylcysteine 200mg/ml Injection

PL 12064/0026

Batch Number Expiry Date  Pack Size First Distributed
80455 01 Oct 2010 10 x 10ml 12 Nov 2008
90114 30 Jun 2011 10 x 10ml 13 Aug 2009
 
 
 
 
 
Please replace the Drug Alert issued on 24 June 2010 with this revised document.
 
Aurum Pharmaceuticals Limited has informed us that the two affected batches were packed in Martindale Pharma livery. In addition, the expiry date for batch 90114 has been corrected to 30 Jun 2011.
 

Aurum Pharmaceuticals Limited has informed us that black particles have been found in a very small number of ampoules from the above batches. Investigation has confirmed that the particles comprise carbonised material which forms if droplets of solution are present during sealing of the ampoules. Particles may be suspended in the solution, or may adhere to the inner wall of the ampoule neck in which case they may not be dislodged by shaking.

In order to avoid stock shortages, these batches are not being recalled. Provided this product is inspected as per normal parenteral practices, any affected ampoules should be detected and discarded.

For medical information enquiries please contact Aurum Pharmaceuticals Limited medical information on 01708 382791.

Recipients of this Drug Alert are requested to bring it to the attention of relevant professionals by copy of this letter.

Yours faithfully

Alison Bunce
Pharmaceutical Assessor, DMRC

 

MHRA Distribution (further recipients by cascade):
Regional contacts for NHS trusts and provider units
Chief pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special hospitals
Healthcare Commission for distribution to independent health care establishments
Primary care trusts (England)
Page last modified: 22 November 2010